OTC: SGMO
SANGAMO THERAPEUTICS, INCCIK 0001001233 · Biological Products
Micro
Revenue $40M
Assets $60M
as of Jun 24, 2026
Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.
Sign up freeWant to see a complete report first? Today's free report (CNTA 8-K) is open in full — no account needed.
8-K
Filed Jun 23, 2026
· Period ending Jun 18, 2026
Summary not yet generated.
10-Q
Filed May 14, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
Partner
Trade SGMO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed May 14, 2026
· Period ending May 14, 2026
Summary not yet generated.
8-K
Filed Apr 29, 2026
· Period ending Apr 28, 2026
Summary not yet generated.
10-K
Filed Mar 30, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Nov 6, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-K
Filed Mar 17, 2025
· Period ending Dec 31, 2024
Summary not yet generated.